Published in World J Gastroenterol on August 14, 2016
Pathophysiology of Gastric NETs: Role of Gastrin and Menin. Curr Gastroenterol Rep (2017) 0.75
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol (2008) 15.05
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86
Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology (1993) 4.04
The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am (2011) 2.95
Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer (2005) 2.40
Review article: the investigation and management of gastric neuroendocrine tumours. Aliment Pharmacol Ther (2014) 2.28
Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol (2010) 2.18
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer (2008) 2.11
Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology (1995) 2.03
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology (2012) 1.86
Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer (2010) 1.85
Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study. Cancer Res Treat (2012) 1.76
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology (2012) 1.68
A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol (2004) 1.67
Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol (2005) 1.65
Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol (2010) 1.65
Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy (2010) 1.60
Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol (1999) 1.59
Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Aliment Pharmacol Ther (2012) 1.57
A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol (2007) 1.56
Gastrinoma (duodenal and pancreatic). Neuroendocrinology (2007) 1.55
Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases. Arch Pathol Lab Med (1990) 1.51
Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw (2015) 1.51
Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer (1999) 1.50
Laparoscopic antrectomy for the treatment of type I gastric carcinoid tumors. J Surg Res (2010) 1.47
Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome. Cancer (2011) 1.46
Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg (2004) 1.45
Microcarcinoid tumor diagnosed with high-resolution magnification endoscopy and narrow band imaging. Endoscopy (2008) 1.45
Accuracy of EUS in the evaluation of small gastric subepithelial lesions. Gastrointest Endosc (2010) 1.43
Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol (2014) 1.39
Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) (2004) 1.39
Carcinoid tumors of the duodenum. Surgery (2005) 1.37
The role of surgery in the Zollinger-Ellison syndrome. Ann Surg (1983) 1.36
Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management. World J Gastrointest Endosc (2010) 1.33
Surgery increases survival in patients with gastrinoma. Ann Surg (2006) 1.26
From the archives of the AFIP: Gastrointestinal carcinoids: imaging features with clinicopathologic comparison. Radiographics (2007) 1.24
Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. Hum Pathol (2011) 1.22
Endocrinocarcinomas (carcinoids and their variants) of the duodenum. An evaluation of 927 cases. J Exp Clin Cancer Res (2003) 1.22
Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg (1994) 1.21
Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome? Ann Surg (2004) 1.20
Tumour biology and histopathology of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab (2007) 1.20
Neuroendocrine neoplasms of the gastrointestinal tract: classification, pathologic basis, and imaging features. Radiographics (2007) 1.15
Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery (1995) 1.14
Duodenal carcinoid tumors: 5 cases treated by endoscopic submucosal dissection. Gastrointest Endosc (2011) 1.08
Minimally invasive surgery for resection of duodenal carcinoid tumors: endoscopic full-thickness resection under laparoscopic observation. Surg Endosc (2009) 1.07
Current concepts on gastric carcinoid tumors. Gastroenterol Res Pract (2012) 1.04
Successful closing of duodenal ulcer after endoscopic submucosal dissection with over-the-scope clip to prevent delayed perforation. Dig Endosc (2012) 1.01
Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg (2005) 0.98
Management of patients with Zollinger-Ellison syndrome. Annu Rev Med (1995) 0.98
Duodenal carcinoids: imaging features with clinical-pathologic comparison. Radiology (2005) 0.98
Presentation, treatment, and outcome of type 1 gastric carcinoid tumors. J Surg Oncol (2006) 0.97
Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study. J Gastroenterol Hepatol (2014) 0.94
Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients. World J Gastroenterol (2011) 0.94
Long-term follow up of endoscopic resection for type 3 gastric NET. World J Gastroenterol (2013) 0.94
Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor. World J Surg (2011) 0.94
Sporadic duodenal bulb gastrin-cell tumors: association with Helicobacter pylori gastritis and long-term use of proton pump inhibitors. Am J Surg Pathol (2006) 0.94
Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry. Pathol Oncol Res (2011) 0.94
Standard imaging techniques for neuroendocrine tumors. Endocrinol Metab Clin North Am (2011) 0.93
Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study. Eur J Endocrinol (2013) 0.92
PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature. Future Oncol (2014) 0.92
Endoscopic tissue shielding method with polyglycolic acid sheets and fibrin glue to prevent delayed perforation after duodenal endoscopic submucosal dissection. Dig Endosc (2014) 0.92
Recent standardization of treatment strategy for pancreatic neuroendocrine tumors. World J Gastroenterol (2010) 0.91
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs. Endocr Relat Cancer (2008) 0.91
Carcinoid tumor of the duodenum: a rare tumor at an unusual site. Case series from a single institution. Arq Gastroenterol (2013) 0.90
Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors. World J Gastroenterol (2014) 0.89
Gastric and duodenal neuroendocrine tumours. Best Pract Res Clin Gastroenterol (2012) 0.89
Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue. Eur J Gastroenterol Hepatol (2007) 0.89
Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study. J Gastrointest Surg (2013) 0.88
Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection. Dig Dis Sci (2002) 0.88
Gastric neuroendocrine tumours. Dig Surg (2012) 0.87
Defining surgical indications for type I gastric carcinoid tumor. Ann Surg Oncol (2009) 0.86
Foregut carcinoids: a clinical and biochemical analysis. Surgery (1999) 0.85
Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours. Eur J Endocrinol (2008) 0.85
Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumours. Dig Liver Dis (2007) 0.85
A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis. J Gastrointest Surg (2016) 0.83
Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors. Scand J Gastroenterol (2015) 0.83
Gastric carcinoids: between underestimation and overtreatment. World J Gastroenterol (2009) 0.83
Endoscopic resection with the cap technique of a carcinoid tumor in the duodenal bulb. Endoscopy (2009) 0.83
Small bowel carcinoid: Location isn't everything! World J Gastrointest Surg (2013) 0.83
Gastric neuroendocrine neoplasms and related precursor lesions. J Clin Pathol (2014) 0.81
Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids. Scand J Gastroenterol (2010) 0.80
Endoscopic diagnosis and management of type I neuroendocrine tumors. World J Gastrointest Endosc (2015) 0.79
Somatostatin analogs for gastric carcinoids: For many, but not all. World J Gastroenterol (2015) 0.79
Usefulness of endoscopic submucosal dissection for type I gastric carcinoid tumors compared with endoscopic mucosal resection. Hepatogastroenterology (2013) 0.79
Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis. Dig Liver Dis (2015) 0.78
Management and clinical outcomes of type I gastric carcinoid patients: retrospective, multicenter study in Japan. Dig Endosc (2013) 0.78
Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients. Hepatogastroenterology (2005) 0.78
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study. Endocrine (2015) 0.78
Duodenal gastrinoma with multiple gastric neuroendocrine tumors secondary to chronic Helicobacter pylori gastritis. Am J Surg Pathol (2012) 0.77
Future directions of duodenal endoscopic submucosal dissection. World J Gastrointest Endosc (2015) 0.77
Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist. Scand J Gastroenterol (2015) 0.77
Delayed bleeding after endoscopic submucosal dissection for non-ampullary superficial duodenal neoplasias might be prevented by prophylactic endoscopic closure: analysis of risk factors. Dig Endosc (2014) 0.76
Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms. Clin Endocrinol (Oxf) (2014) 0.76
Laparoscopic antrectomy: a safe and definitive treatment in managing type 1 gastric carcinoids. Am J Surg (2016) 0.76
The efficacy of endoscopic submucosal dissection of type I gastric carcinoid tumors compared with conventional endoscopic mucosal resection. Gastroenterol Res Pract (2014) 0.76